Martínez-Jiménez Jorge E, Sathisaran Indumathi, Reyes Figueroa Francheska, Reyes Stephanie, López-Nieves Marisol, Vlaar Cornelis P, Monbaliu Jean-Christophe M, Romañach Rodolfo, Ruaño Gualberto, Stelzer Torsten, Duconge Jorge
Pharmacogenomics (PGx) Laboratory, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, 00936, United States.
Crystallization Design Institute, Molecular Sciences Research Center, University of Puerto Rico, San Juan, PR, 00926, United States.
Int J Pharm. 2025 Feb 10;670:125070. doi: 10.1016/j.ijpharm.2024.125070. Epub 2024 Dec 15.
Over the next decade, Precision Medicine (PM) is poised to become the standard of care in pharmaceutical therapy, necessitating a fundamental transformation in the design and development of innovative custom-made drug products. To date, a comprehensive review linking PM with practical personalized drug formulations is missing. This review attempts to provide an overview of state-of-the-art formulation approaches capable of translating PM evaluation and resulting recommendations (clinical research) into tailored drug products (non-clinical research) for real-world patients. Comprehensive literature searches in four scientific databases (Scopus, SciFinder, Web of Science, and PubMed) were performed. Current approaches to point-of-care PM formulations and needs-based locally distributed manufacturing presently under research & development (R&D) as alternatives to conventional large-scale manufacturing of one-size-fits-all drug products are discussed. The following methods were identified as the most promising PM formulation strategies: tablet splitting, liquid dispensing, compounding pharmacies, additive manufacturing, drug impregnation, drug extrusion, and orodispersible films (ODFs). The challenges and opportunities of current state-of-the-art formulation technologies that can enable making PM routinely accessible in practice settings will be discussed. Additionally, light will be shed on point-of-use manufacturing (Pharmacy on Demand) as an uncharted territory for PM and its pathway towards practical implementation.
在接下来的十年里,精准医学(PM)有望成为药物治疗的护理标准,这就需要对创新定制药品的设计和开发进行根本性变革。迄今为止,尚缺乏将精准医学与实用的个性化药物制剂联系起来的全面综述。本综述试图概述一些先进的制剂方法,这些方法能够将精准医学评估及所得建议(临床研究)转化为针对现实世界患者的定制药品(非临床研究)。我们在四个科学数据库(Scopus、SciFinder、科学网和PubMed)中进行了全面的文献检索。讨论了即时护理精准医学制剂的当前方法以及作为传统大规模生产一刀切药品的替代方案、目前正在研发的基于需求的本地分布式制造。以下方法被确定为最有前景的精准医学制剂策略:片剂分割、液体调配、复方药房、增材制造、药物浸渍、药物挤出和口腔崩解膜(ODF)。将讨论当前先进制剂技术在实际应用中实现精准医学常规应用的挑战和机遇。此外,还将探讨即时使用制造(按需药房)作为精准医学的未知领域及其实际实施途径。